33rd Annual New Treatments in Chronic Liver Disease

The 33rd Annual New Treatments in Chronic Liver Disease 2018 will be held in La Jolla, CA, United States on March 9-11, 2018.

The 33rd Annual New Treatments in Chronic Liver Disease 2018 is a course dedicated to new medications and therapies in the treatment of the following:

• Current knowledge of NAFLD and non-alcoholic steatohepatitis and the use of new agents and approaches to treatment of the conditions
• The details of the AASLD guidelines for treatment of HCV using DAAs in IFN-free regimens
• Therapies for HCV including NS5A, protease and polymerase inhibitors
• The algorithm for a therapeutic approach to treatment of HBV using anti-virals
• Current options of therapy for hepatocellular carcinoma to determine the best approach for your patients
• The skills and management required for transplant hepatology
• The diagnosis and treatment of PBC and PSC
• Future treatment paradigms for HCV direct-acting antiviral drug
• The issues complicating drug treatment in decompensated cirrhosis, hepatic encephalopathy and hyponatremia
• Treatment options discussed for patients with ESLD due to alcohol who have complicating factors such as HCV, NASH or inherited genetic disorder
• The management of complications beta-blocker therapy in ESLD

The 33rd Annual New Treatments in Chronic Liver Disease 2018 brings together Hepatologists, Physician Assistants , Residents/Fellows, Nurses, Nurse Practitioners, Gastroenterologists, Infectious Disease Specialists and others desiring an update in these specialty areas.